Press Release

Dawn Health and Novartis Israel announce clinical study collaboration utilizing Ekiva MS

Copenhagen  —

August 20, 2026

DHDK_EKVMS2.0_002_V0

Dawn Health today announces the initiation of a research collaboration with Novartis Israel and Clalit Health Services, through Carmel Medical Center in Haifa, Israel. The collaboration relates to the execution of a clinical study in which the Ekiva MS digital application will be utilized.

The study is sponsored by Clalit Health Services through Carmel Medical Center, with funding provided by Novartis. Dawn Health is acting as the application provider and technical implementation partner for the duration of the study.

The collaboration has a planned duration of forty-four months. During this period, Dawn Health will provide access to the Ekiva MS application for study participants and designated healthcare professionals in alignment with the defined study requirements.

The application will be localized into Hebrew, including professional translation, linguistic validation, and quality assurance processes. Study-specific technical configurations will be implemented, including the development of a healthcare professional dashboard for structured data review.

A joint core project team comprising representatives from Novartis and Dawn Health has been established to oversee implementation and monitor progress throughout the study.

“We are pleased to support the implementation of Ekiva MS within this clinical study,” said Alexander Mandix Hansen, CEO of Dawn Health. “Digital applications are increasingly being incorporated into structured research environments, and this collaboration reflects the operational role that digital solutions can play when deployed in alignment with defined clinical protocols.”

No study results are available at this stage. Further information may be communicated upon study completion, subject to applicable approvals.

About Dawn Health

Dawn Health designs, builds, and scales digital health products for pharmaceutical companies and healthcare partners worldwide. The company specializes in therapy companions, disease management solutions, clinical support tools, and AI-enabled patient applications built to integrate with enterprise healthcare infrastructure.

Media contact

Christopher Kold

Marketing Manager

+45 4158 6088

cko@dawnhealth.com